Figure 7
Figure 7. Msr1 does not affect BCR-ABL–induced lymphoid leukemia. (A) Kaplan-Meier survival curves for recipients of BCR-ABL–transduced bone marrow cells from WT (n = 10) or Msr1−/− (n = 8) donor mice. Both groups of mice developed and died of ALL. (B-C) FACS analysis showed similar numbers of GFP+B220+ cells in peripheral blood of recipients of BCR-ABL–transduced bone marrow cells from WT (n = 5) or Msr1−/− (n = 5) donor mice. (D) Spleen masses of recipients of BCR-ABL–transduced bone marrow cells from Msr1−/− (n = 9) donor mice is similar to WT (n = 4) donor mice.

Msr1 does not affect BCR-ABL–induced lymphoid leukemia. (A) Kaplan-Meier survival curves for recipients of BCR-ABL–transduced bone marrow cells from WT (n = 10) or Msr1−/− (n = 8) donor mice. Both groups of mice developed and died of ALL. (B-C) FACS analysis showed similar numbers of GFP+B220+ cells in peripheral blood of recipients of BCR-ABL–transduced bone marrow cells from WT (n = 5) or Msr1−/− (n = 5) donor mice. (D) Spleen masses of recipients of BCR-ABL–transduced bone marrow cells from Msr1−/−(n = 9) donor mice is similar to WT (n = 4) donor mice.

Close Modal

or Create an Account

Close Modal
Close Modal